How much did Fathom Therapeutics raise?

Fathom Therapeutics raised $47M at Series A, announced 27 April 2026.

Who founded Fathom Therapeutics?

Huafeng Xu is CEO & Co-founder of Fathom Therapeutics.

What does Fathom Therapeutics do?

Fathom Therapeutics operates in HealthTech and is based in United States.

FundedStartupsDaily / HealthTech / Fathom Therapeutics

Fathom Therapeutics raises $47M

Fathom Therapeutics announced a Series A round of $47M on 27 April 2026. The company operates in HealthTech and is based in United States. It was founded by Huafeng Xu, CEO & Co-founder.

Raised

$47M

Stage

Series A

Industry

HealthTech

Country

United States

Founder

Huafeng Xu

CEO & Co-founder, Fathom Therapeutics

LinkedIn profile fathomtx.com

Outreach angles

-Built drug discovery careers across multiple labs before co-founding Atommap, the predecessor to Fathom Therapeutics, alongside two PhD computational scientists.
-Co-founded the company with former Roivant and Schrodinger pioneers Yujie Wu and Jesus Izaguirre who specialize in molecular modeling.
-$47M oversubscribed Series A led by Sutter Hill Ventures funds the rebrand from Atommap and the scale-up of the Microcosmos protein dynamics platform.